Source comparison
Pulsatile Secretion Pattern Versus Continuous Elevation
One reason tesamorelin popular in longitudinal studies is preservation of pulsatile GH secretion architecture. The human somatotroph axis operates on a tightly regulated ultradian rhythm: GH peaks occur roughly every 3–5 hours, predominantly during slow-wave s
This comparison does not assign a generated winner or score.
- One reason tesamorelin popular in longitudinal studies is preservation of pulsatile GH secretion architecture. The human somatotroph axis operates on a tightly regulated ultradian rhythm: GH peaks occur roughly every 3–5 hours, predominantly during slow-wave sleep, triggered by GHRH release from the arcuate nucleus. Somatostatin (SRIF) from periventricular neurons suppresses GH between pulses, creating the oscillatory pattern essential for metabolic signaling.
- Exogenous GH administration bypasses this entirely. Plasma GH remains elevated continuously, which triggers negative feedback at the hypothalamus. After 2–4 weeks of daily GH injections, endogenous pulsatility is suppressed, IGF-1 production shifts disproportionately hepatic (rather than paracrine), and the metabolic benefits plateau. Recovery of natural GH secretion after cessation can take 4–8 weeks.
- Tesamorelin doesn't suppress endogenous production because it works upstream. It mimics GHRH, the signal that tells somatotrophs to release GH, rather than replacing GH itself. Clinical pharmacokinetic data show that subcutaneous tesamorelin administration produces a GH peak at 30–60 minutes post-injection, followed by return to baseline within 3–4 hours. The pituitary remains responsive to endogenous GHRH pulses throughout the dosing interval, so circadian GH architecture stays intact. That's why tesamorelin popular in studies requiring months of continuous dosing. Receptor function doesn't degrade.